IBI: AN457; Milica Pešić***, naučni savetnik, Univerzitet u Beogradu, Institut za biološka istraživanja 'Siniša Stanković'; Polje: prirodno-matematičke i medicinske nauke; Period: 2020-2024;
eNauka profil: rp08606; ORCID: 0000-0002-9045-8239;
WOS indikatori: NR = 121; TC = 2359; HIndex = 28;
eNauka WOS indikatori: NR = 137; TC = 2361; HIndex = 29 ;
Lista A broj bodova: 324.7022 (552) 4.0%; Lista B broj bodova: 1373.4959 (552) 10.7%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 0.00312 (373) 83.6%; Lista B broj bodova kolaboracije: 10.00115 (373) 30.8%;
Statistika svih rezultata
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata | 121 | 97 | 84 | 64 | 42 |
| Broj citata | 2359 | 1899 | |||
| Broj M bodova | 411.00 | 411 | 411.00 | 411 | |
| Normirani broj citata | 1725.04 | 1373.49 | |||
| Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M24 | 324.70 | 324.70 | 324.70 | 324.70 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M42 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M51 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M43+M44 | 0.00 | 0.00 | 0.00 | 0.00 |
Statistika rezultata nastalih u medunarodnim kolaboracijama
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata sa 20 i više autora | 1 | 1 | 1 | 1 | 0 |
| Broj citata rezultata sa 20 i više autora | 39 | 36 | |||
| Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0 | 0.00 | 0 | |
| Normirani broj citata rezultata sa 20 i više autora | 10.83 | 10.00 | |||
| Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0.00 |
Rezultati
| RB | IBI | Godina | Kat | Tip | Vrsta | Referenca | TC | TCP | BA | NBB | NTC | Naslov | Autori | 1. | AN457 | 2000 | E | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS Vol. 19 (5-6): # 963 - 975 (13), (DOI: 10.1080/15257770008033036) 2000WOS | 12 | 1 | 6 | 0 | 1.0000 | Inhibition of cell growth and proliferation in human glioma cells and normal human astrocytes induced by 8-Cl-cAMP and tiazofurin | Pesic M, Drabek K, Esler C, Ruzdijic S, Pejanovic V, Pietrzkowski Z | 2. | AN457 | 2000 | E | ANTI-CANCER DRUGS Vol. 11 (9): # 765 - 770 (6), (DOI: 10.1097/00001813-200010000-00014) OCT 2000WOS | 11 | 3 | 7 | 0 | 3.0000 | 8-Cl-cAMP and tiazofurin affect vascular endothelial growth factor production and glial fibrillary acidic protein expression in human glioblastoma cells | Drabek K, Pesic M, Piperski V, Ruzdijic S, Medic-Mijacevic L, Pietrzkowski Z, Rakic L | 3. | AN457 | 2001 | E | JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY Vol. 20 (1): # 9 - 18 (10), (DOI: ) JAN-MAR 2001WOS | 5 | 1 | 11 | 0 | 0.5556 | Downregulation of c-fos and c-myc expression and apoptosis induction by tiazofurin and 8-Cl-cAMP in human melanoma cells | Ruzdijic S, Milosevic J, Popovic N, Pesic M, Stojilkovic M, Kanazir S, Todorovic D, Ristic-Fira A, Krstic-Demonacos M, Kanazir D, Rakic L | 4. | AN457 | 2006 | E | INVESTIGATIONAL NEW DRUGS Vol. 24 (1): # 15 - 25 (11), (DOI: 10.1007/s10637-005-4539-8) JAN 2006WOS | 9 | 0 | 7 | 0 | 0.0000 | The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro | Jankovic D, Pesic M, Markovic J, Kanazir S, Markovic I, Rakic L, Ruzdijic S | 5. | AN457 | 2006 | E | JOURNAL OF CHEMOTHERAPY Vol. 18 (1): # 66 - 73 (8), (DOI: 10.1179/joc.2006.18.1.66) FEB 2006WOS | 90 | 53 | 7 | 0 | 53.0000 | Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs | Pesic M, Markovic J, Jankovic D, Kanazir S, Markovic I, Rakic L, Ruzdijic S | 6. | AN457 | 2006 | E | NEUROBIOLOGICAL STUDIES - FROM GENES TO BEHAVIOUR 2006 Vol. (): # 1 - 19 (19), (DOI: ) 2006WOS | 0 | 0 | 5 | 0 | 0.0000 | The role of genetic instability in the development of the multidrug resistance phenotype in brain tumors | Ruzdijic S, Pesic M, Kanazir S, Rakie L, Tanic N | 7. | AN457 | 2008 | E | CANCER BIOLOGY & THERAPY Vol. 7 (7): # 1024 - 1032 (9), (DOI: 10.4161/cbt.7.7.6036) JUL 2008WOS | 48 | 31 | 6 | 0 | 31.0000 | Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R) | Andjelkovic T, Pesic M, Bankovic J, Tanic N, Markovic I, Ruzdijic S | 8. | AN457 | 2009 | E | INVESTIGATIONAL NEW DRUGS Vol. 27 (2): # 99 - 110 (12), (DOI: 10.1007/s10637-008-9140-5) APR 2009WOS | 8 | 2 | 6 | 0 | 2.0000 | Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R) | Pesic M, Andjelkovic T, Bankovic J, Markovic I, Rakic L, Ruzdijic S | 9. | AN457 | 2010 | E | INVESTIGATIONAL NEW DRUGS Vol. 28 (4): # 482 - 492 (11), (DOI: 10.1007/s10637-009-9277-x) AUG 2010WOS | 6 | 1 | 4 | 0 | 1.0000 | Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil | Pesic M, Podolski A, Rakic L, Ruzdijic S | 10. | AN457 | 2011 | E | BIOMEDICINE & PHARMACOTHERAPY Vol. 65 (5): # 345 - 353 (9), (DOI: 10.1016/j.biopha.2011.04.015) AUG 2011WOS | 68 | 48 | 6 | 0 | 48.0000 | The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines | Podolski-Renic A, Andelkovic T, Bankovic J, Tanic N, Ruzdijic S, Pesic M | 11. | AN457 | 2011 | E | FOOD AND CHEMICAL TOXICOLOGY Vol. 49 (12): # 3165 - 3173 (9), (DOI: 10.1016/j.fct.2011.09.035) DEC 2011WOS | 29 | 24 | 12 | 0 | 12.0000 | New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides | Pesic M, Bankovic J, Aljancic I, Todorovic N, Jadranin M, Vajs V, Tekvic V, Vuckovic I, Momcilovic M, Markovic I, Tanic N, Ruzdijic S | 12. | AN457 | 2011 | E | JOURNAL OF NATURAL PRODUCTS Vol. 74 (7): # 1613 - 1620 (8), (DOI: 10.1021/np200241c) JUL 2011WOS | 52 | 40 | 13 | 0 | 18.1818 | Isolation and Biological Evaluation of Jatrophane Diterpenoids from Euphorbia dendroides | Aljancic I, Pesic M, Milosavljevic S, Todorovic N, Jadranin M, Miosavljevic G, Povrenovic D, Bankovic J, Tanic N, Markovic I, Ruzdijic S, Vajs V, Tesevic V | 13. | AN457 | 2011 | E | CANCER BIOMARKERS Vol. 10 (6): # 277 - 286 (10), (DOI: 10.3233/CBM-2012-0257) 2011WOS | 8 | 5 | 8 | 0 | 4.1667 | Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients | Andjelkovic T, Bankovic J, Milosevic Z, Stojsic J, Milinkovic V, Pesic M, Ruzdijic S, Tanic N | 14. | AN457 | 2012 | E | EXPERIMENTAL AND MOLECULAR PATHOLOGY Vol. 93 (2): # 200 - 206 (7), (DOI: 10.1016/j.yexmp.2012.05.010) OCT 2012WOS | 22 | 16 | 12 | 0 | 8.0000 | Genomic instability and p53 alterations in patients with malignant glioma | Milinkovic V, Bankovic J, Rakic M, Milosevic N, Stankovic T, Jokovic M, Milosevic Z, Skender-Gazibara M, Podolski-Renic A, Pesic M, Ruzdijic S, Tanic N | 15. | AN457 | 2013 | E | CANCER CHEMOTHERAPY AND PHARMACOLOGY Vol. 72 (3): # 683 - 697 (15), (DOI: 10.1007/s00280-013-2247-1) SEP 2013WOS | 37 | 33 | 13 | 0 | 15.0000 | Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing | Podolski-Renic A, Jadranin M, Stankovic T, Bankovic J, Stojkovic S, Chiourea M, Aljancic I, Vajs V, Tesevic V, Ruzdijic S, Gagos S, Tanic N, Pesic M | 16. | AN457 | 2013 | E | JOURNAL OF MOLECULAR STRUCTURE Vol. 1040 (): # 216 - 220 (5), (DOI: 10.1016/j.molstruc.2013.03.013) MAY 22 2013WOS | 16 | 15 | 9 | 0 | 10.7143 | Synthesis, characterization and cytotoxicity of a new palladium(II) complex with a coumarin-derived ligand. Crystal structure of 4-hydroxy-3-(1-(p-tolylimino)ethyl)-2H-chromen-2-one-palladium(II) complex | Jevtic V, Pesic M, Radic G, Vukovic N, Sukdolak S, Klisuric O, Podolski-Renic A, Tanic N, Trifunovic S | 17. | AN457 | 2013 | E | PHYTOCHEMISTRY Vol. 86 (): # 208 - 217 (10), (DOI: 10.1016/j.phytochem.2012.09.003) FEB 2013WOS | 39 | 35 | 11 | 0 | 19.4444 | Jatrophane diterpenoids from the latex of Euphorbia dendroides and their anti-P-glycoprotein activity in human multi-drug resistant cancer cell lines | Jadranin M, Pesic M, Aljancic I, Milosavljevic S, Todorovic N, Podolski-Renic A, Bankovic J, Tanic N, Markovic I, Vajs V, Tesevic V | 18. | AN457 | 2013 | E | PHYTOCHEMISTRY LETTERS Vol. 6 (2): # 246 - 252 (7), (DOI: 10.1016/j.phytol.2013.02.006) MAY 2013WOS | 44 | 39 | 8 | 0 | 32.5000 | Cytotoxic activity of sesquiterpene lactones from Inula britannica on human cancer cell lines | Fischedick J, Pesic M, Podolski-Renic A, Bankovic J, de V, Peric M, Todorovic S, Tanic N | 19. | AN457 | 2013 | E | EXPERIMENTAL CELL RESEARCH Vol. 319 (7): # 1013 - 1027 (15), (DOI: 10.1016/j.yexcr.2012.12.017) APR 15 2013WOS | 34 | 26 | 10 | 0 | 16.2500 | The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: The unique way of multi-drug resistance modulation | Bankovic J, Andrä J, Todorovic N, Podolski-Renic A, Milosevic Z, Miljkovic D, Krause J, Ruzdijic S, Tanic N, Pesic M | 20. | AN457 | 2013 | E | PLOS ONE Vol. 8 (1): #e54044 - (15), (DOI: 10.1371/journal.pone.0054044) JAN 11 2013WOS | 19 | 18 | 9 | 0 | 12.8571 | Purine Nucleoside Analog - Sulfinosine Modulates Diverse Mechanisms of Cancer Progression in Multi-Drug Resistant Cancer Cell Lines | Dacevic M, Isakovic A, Podolski-Renic A, Isakovic A, Stankovic T, Milosevic Z, Rakic L, Ruzdijic S, Pesic M | 21. | AN457 | 2013 | E | JOURNAL OF MEDICAL BIOCHEMISTRY Vol. 32 (4): # 406 - 416 (11), (DOI: 10.2478/jomb-2013-0050) OCT 2013WOS | 2 | 2 | 11 | 0 | 1.1111 | NO-MODIFIED SAQUINAVIR IS EQUALLY EFFICIENT AGAINST DOXORUBICIN SENSITIVE AND RESISTANT NON-SMALL CELL LUNG CARCINOMA CELLS | Mijatovic S, Pesic M, Mojic M, Bankovic J, Miljkovic D, Fagone P, Mangano K, Nicoletti F, McCubrey J, Tanic N, Maksimovic-Ivanic D | 22. | AN457 | 2014 | E | CHEMMEDCHEM Vol. 9 (5): # 973 - 983 (11), (DOI: 10.1002/cmdc.201400044) MAY 2014WOS | 34 | 33 | 12 | 0 | 16.5000 | Discovery of 14-3-3 Protein- Protein Interaction Inhibitors that Sensitize Multidrug- Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 | Mori M, Vignaroli G, Cau Y, Dinic J, Hill R, Rossi M, Colecchia D, Pesic M, Link W, Chiariello M, Ottmann C, Botta M | 23. | AN457 | 2014 | E | PHYTOCHEMISTRY Vol. 97 (): # 46 - 54 (9), (DOI: 10.1016/j.phytochem.2013.11.001) JAN 2014WOS | 37 | 32 | 11 | 0 | 17.7778 | Diarylheptanoids from the bark of black alder inhibit the growth of sensitive and multi-drug resistant non-small cell lung carcinoma cells | Novakovic M, Pesic M, Trifunovic S, Vuckovic I, Todorovic N, Podolski-Renic A, Dinic J, Stojkovic S, Tesevic V, Vajs V, Milosavljevic S | 24. | AN457 | 2014 | E | PHYTOCHEMISTRY Vol. 98 (): # 190 - 196 (7), (DOI: 10.1016/j.phytochem.2013.11.025) FEB 2014WOS | 28 | 27 | 10 | 0 | 16.8750 | Two structurally distinct chalcone dimers from Helichrysum zivojinii and their activities in cancer cell lines | Aljancic I, Vuckovic I, Jadranin M, Pesic M, Dordevic I, Podolski-Renic A, Stojkovic S, Menkovic N, Vajs V, Milosavljevic S | 25. | AN457 | 2014 | E | TRANSLATIONAL RESEARCH Vol. 164 (5): # 411 - 423 (13), (DOI: 10.1016/j.trsl.2014.06.005) NOV 2014WOS | 47 | 42 | 9 | 0 | 30.0000 | Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma | Milosevic Z, Pesic M, Stankovic T, Dinic J, Milovanovic Z, Stojsic J, Dzodic R, Tanic N, Bankovic J | 26. | AN457 | 2014 | E | METABOLIC ENGINEERING Vol. 23 (): # 145 - 153 (9), (DOI: 10.1016/j.ymben.2014.03.005) MAY 2014WOS | 68 | 60 | 11 | 0 | 33.3333 | Elucidation and in planta reconstitution of the parthenolide biosynthetic pathway | Liu Q, Manzano D, Tanic N, Pesic M, Bankovic J, Pateraki I, Ricard L, Ferrer A, de V, van d, Bouwmeester H | 27. | AN457 | 2014 | E | PLANTA MEDICA Vol. 80 (13): # 1088 - 1096 (9), (DOI: 10.1055/s-0034-1382993) AUG 2014WOS | 18 | 15 | 9 | 0 | 10.7143 | Antioxidative Activity of Diarylheptanoids from the Bark of Black Alder (Alnus glutinosa) and Their Interaction with Anticancer Drugs | Dinic J, Novakovic M, Podolski-Renic A, Stojkovic S, Mandic B, Tesevic V, Vajs V, Isakovic A, Pesic M | 28. | AN457 | 2015 | E | CANCER CHEMOTHERAPY AND PHARMACOLOGY Vol. 76 (3): # 555 - 565 (11), (DOI: 10.1007/s00280-015-2821-9) SEP 2015WOS | 18 | 15 | 10 | 0 | 9.3750 | Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives | Stankovic T, Dankó B, Martins A, Dragoj M, Stojkovic S, Isakovic A, Wang H, Wu Y, Hunyadi A, Pesic M | 29. | AN457 | 2015 | E | TUMOR BIOLOGY Vol. 36 (11): # 8773 - 8780 (8), (DOI: 10.1007/s13277-015-3620-y) NOV 2015WOS | 15 | 14 | 7 | 0 | 14.0000 | Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome | Dragoj M, Milosevic Z, Bankovic J, Dinic J, Pesic M, Tanic N, Stankovic T | 30. | AN457 | 2015 | E | CHEMICO-BIOLOGICAL INTERACTIONS Vol. 232 (): # 85 - 93 (9), (DOI: 10.1016/j.cbi.2015.03.013) MAY 5 2015WOS | 133 | 113 | 13 | 0 | 51.3636 | Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity | Pesic M, Podolski-Renic A, Stojkovic S, Matovic B, Zmejkoski D, Kojic V, Bogdanovic G, Pavicevic A, Mojovic M, Savic A, Milenkovic I, Kalauzi A, Radotic K | 31. | AN457 | 2015 | E | FITOTERAPIA Vol. 105 (): # 169 - 176 (8), (DOI: 10.1016/j.fitote.2015.07.003) SEP 2015WOS | 15 | 14 | 7 | 0 | 14.0000 | Chemo-protective and regenerative effects of diarylheptanoids from the bark of black alder (Alnus glutinosa) in human normal keratinocytes | Dinic J, Randelovic T, Stankovic T, Dragoj M, Isakovic A, Novakovic M, Pesic M | 32. | AN457 | 2015 | E | EXPERIMENTAL CELL RESEARCH Vol. 335 (2): # 248 - 257 (10), (DOI: 10.1016/j.yexcr.2015.05.018) JUL 15 2015WOS | 18 | 17 | 10 | 0 | 10.6250 | Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin | Stojkovic S, Podolski-Renic A, Dinic J, Stankovic T, Bankovic J, Hadzic S, Paunovic V, Isakovic A, Tanic N, Pesic M | 33. | AN457 | 2015 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 21 (38): # 5589 - 5604 (16), (DOI: 10.2174/1381612821666151002113546) 2015WOS | 39 | 36 | 5 | 0 | 36.0000 | New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer | Dinic J, Podolski-Renic A, Stankovic T, Bankovic J, Pesic M | 34. | AN457 | 2016 | E | BULLETIN OF MATHEMATICAL BIOLOGY Vol. 78 (6): # 1218 - 1237 (20), (DOI: 10.1007/s11538-016-0182-0) JUN 2016WOS | 10 | 9 | 7 | 0 | 9.0000 | Transfer of Drug Resistance Characteristics Between Cancer Cell Subpopulations: A Study Using Simple Mathematical Models | Durán M, Podolski-Renic A, Alvarez-Arenas A, Dinic J, Belmonte-Beitia J, Pesic M, Pérez-García V | 35. | AN457 | 2016 | E | CHEMICO-BIOLOGICAL INTERACTIONS Vol. 249 (): # 36 - 45 (10), (DOI: 10.1016/j.cbi.2016.02.019) APR 5 2016WOS | 8 | 6 | 7 | 0 | 6.0000 | Structural differences in diarylheptanoids analogues from Alnus viridis and Alnus glutinosa influence their activity and selectivity towards cancer cells | Dinic J, Novakovic M, Podolski-Renic A, Vajs V, Tesevic V, Isakovic A, Pesic M | 36. | AN457 | 2016 | E | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Vol. 118 (): # 107 - 120 (14), (DOI: 10.1016/j.ejmech.2016.04.011) AUG 8 2016WOS | 8 | 6 | 7 | 0 | 6.0000 | Simple avarone mimetics as selective agents against multidrug resistant cancer cells | Jeremic M, Pesic M, Dinic J, Bankovic J, Novakovic I, Segan D, Sladic D | 37. | AN457 | 2016 | E | MEDCHEMCOMM Vol. 7 (12): # 2265 - 2281 (17), (DOI: 10.1039/c6md00391e) 2016WOS | 2 | 1 | 6 | 0 | 1.0000 | Mutual regulation and targeting of multidrug resistance and cancer stem phenotype | Podolski-Renic A, Milosevic Z, Dinic J, Stankovic T, Bankovic J, Pesic M | 38. | AN457 | 2016 | E | CURRENT CANCER DRUG TARGETS Vol. 16 (3): # 226 - 237 (12), (DOI: 10.2174/1568009616666151113120705) 2016WOS | 35 | 33 | 3 | 0 | 33.0000 | Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models | Xavier C, Pesic M, Vasconcelos M | 39. | AN457 | 2016 | E | MOLECULES Vol. 21 (7): #843 - (16), (DOI: 10.3390/molecules21070843) JUL 2016WOS | 11 | 9 | 10 | 0 | 5.6250 | Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells-Characterization of a New in Vivo Model | Stojkovic S, Podolski-Renic A, Dinic J, Pavkovic Z, Ayuso J, Fernández L, Ochoa I, Pérez-García V, Pesic V, Pesic M | 40. | AN457 | 2017 | E | TRANSGENESIS AND SECONDARY METABOLISM Vol. (): # 205 - 230 (26), (DOI: 10.1007/978-3-319-28669-3_5) 2017WOS | 0 | 0 | 6 | 0 | 0.0000 | Secondary Metabolite Profile of Transgenic Centaury (Centaurium erythraea Rafn.) Plants, Potential Producers of Anticancer Compounds | Trifunovic-Momcilov M, Krstic-Milosevic D, Trifunovic S, Podolski-Renic A, Pesic M, Subotic A | 41. | AN457 | 2017 | E | HISTOCHEMISTRY AND CELL BIOLOGY Vol. 148 (5): # 529 - 544 (16), (DOI: 10.1007/s00418-017-1590-4) NOV 2017WOS | 14 | 14 | 6 | 0 | 14.0000 | Targeting autophagy to modulate cell survival: a comparative analysis in cancer, normal and embryonic cells | Rankov A, Ljujic M, Petric M, Radojkovic D, Pesic M, Dinic J | 42. | AN457 | 2017 | E | INVESTIGATIONAL NEW DRUGS Vol. 35 (6): # 718 - 732 (15), (DOI: 10.1007/s10637-017-0494-4) DEC 2017WOS | 9 | 8 | 7 | 0 | 8.0000 | Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors | Dragoj M, Bankovic J, Sereti E, Stojanov S, Dimas K, Pesic M, Stankovic T | 43. | AN457 | 2017 | E | CELLULAR ONCOLOGY Vol. 40 (1): # 47 - 62 (16), (DOI: 10.1007/s13402-016-0304-6) FEB 2017WOS | 42 | 38 | 6 | 0 | 38.0000 | Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma | Dragoj M, Milosevic Z, Bankovic J, Tanic N, Pesic M, Stankovic T | 44. | AN457 | 2017 | E | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES Vol. 105 (): # 159 - 168 (10), (DOI: 10.1016/j.ejps.2017.05.011) JUL 15 2017WOS | 23 | 19 | 10 | 0 | 11.8750 | DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells | Podolski-Renic A, Bankovic J, Dinic J, Ríos-Luci C, Fernandes M, Ortega N, Kovacevic-Grujicic N, Martín V, Padrón J, Pesic M | 45. | AN457 | 2017 | E | SCIENTIFIC REPORTS Vol. 7 (): #44541 - (17), (DOI: 10.1038/srep44541) MAR 17 2017WOS | 69 | 61 | 12 | 0 | 30.5000 | Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles | Lopes-Rodrigues V, Di L, Mleczko J, Meleady P, Henry M, Pesic M, Cabrera D, van L, Lima R, O'Connor R, Falcon-Perez J, Vasconcelos M | 46. | AN457 | 2017 | E | METALLOMICS Vol. 9 (8): # 1132 - 1141 (10), (DOI: 10.1039/c7mt00183e) AUG 1 2017WOS | 38 | 37 | 7 | 0 | 37.0000 | Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel | Podolski-Renic A, Bosze S, Dinic J, Kocsis L, Hudecz F, Csampai A, Pesic M | 47. | AN457 | 2017 | E | JOURNAL OF GLOBAL HEALTH Vol. 7 (2): #020304 - (5), (DOI: 10.7189/jogh.07.020304) DEC 2017WOS | 28 | 22 | 18 | 0 | 6.8750 | Biodiversity, drug discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action | Neergheen-Bhujun V, Awan A, Baran Y, Bunnefeld N, Chan K, Dela C, Egamberdieva D, Elsässer S, Johnson M, Komai S, Konevega A, Malone J, Mason P, Nguon R, Piper R, Shrestha U, Pesic M, Kagansky A | 48. | AN457 | 2018 | E | CELLULAR ONCOLOGY Vol. 41 (4): # 409 - 426 (18), (DOI: 10.1007/s13402-018-0380-x) AUG 2018WOS | 24 | 22 | 12 | 0 | 11.0000 | Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma | Milosevic Z, BankoviAç J, DiniAç J, Tsimplouli C, Sereti E, Dragoj M, PaunoviAç V, MilovanoviAç Z, StepanoviAç M, TaniAç N, Dimas K, PeiAç M | 49. | AN457 | 2018 | E | PHYTOCHEMISTRY Vol. 148 (): # 104 - 112 (9), (DOI: 10.1016/j.phytochem.2018.01.016) APR 2018WOS | 21 | 19 | 7 | 0 | 19.0000 | Jatrophane diterpenoids with multidrug-resistance modulating activity from the latex of Euphorbia nicaeensis | Krstic G, Jadranin M, Todorovic N, Pesic M, Stankovic T, Aljancic I, Tesevic V | 50. | AN457 | 2018 | E | RADIOTHERAPY AND ONCOLOGY Vol. 128 (2): # 236 - 244 (9), (DOI: 10.1016/j.radonc.2018.04.033) AUG 2018WOS | 21 | 18 | 19 | 0 | 5.2941 | Regulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomide | Frontiñán-Rubio J, Santiago-Mora R, Nieva-Velasco C, Ferrín G, Martínez-González A, Gómez M, Moreno M, Ariza J, Lozano E, Arjona-Gutiérrez J, Gil-Agudo A, De l, Pesic M, Peinado J, Villalba J, Pérez-Romasanta L, Pérez-García V, Alcaín F, Durán-Prado M | 51. | AN457 | 2018 | E | ACTA BIOLOGICA HUNGARICA Vol. 69 (4): # 395 - 410 (16), (DOI: 10.1556/018.69.2018.4.3) DEC 2018WOS | 3 | 1 | 7 | 0 | 1.0000 | COMPARATIVE TOXICITY EVALUATION OF TARGETED ANTICANCER THERAPEUTICS IN EMBRYONIC ZEBRAFISH AND SEA URCHIN MODELS | Babic T, Dinic J, Buric S, Hadzic S, Pesic M, Radojkovic D, Rankov A | 52. | AN457 | 2018 | E | EUROPEAN JOURNAL OF HORTICULTURAL SCIENCE Vol. 83 (6): # 374 - 381 (8), (DOI: 10.17660/eJHS.2018/83.6.5) DEC 2018WOS | 5 | 4 | 6 | 0 | 4.0000 | Effects of soil properties and fertilization on quality and biological activity of Swiss chard | Topalovic A, Knezevic M, Trifunovic S, Novakovic M, Pesic M, Durovic D | 53. | AN457 | 2018 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 24 (36): # 4334 - 4354 (21), (DOI: 10.2174/1381612825666190112164211) 2018WOS | 21 | 19 | 4 | 0 | 19.0000 | Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition | Dinic J, Podolski-Renic A, Jeremic M, Pesic M | 54. | AN457 | 2018 | E | JOURNAL OF THE SERBIAN CHEMICAL SOCIETY Vol. 83 (11): # 1193 - 1207 (15), (DOI: 10.2298/JSC180627062J) 2018WOS | 3 | 2 | 7 | 0 | 2.0000 | Alkylamino and aralkylamino derivatives of avarone and its mimetic as selective agents against non-small cell lung cancer cells, their antibacterial and antifungal potential | Jeremic M, Dinic J, Pesic M, Stepanovic M, Novakovic I, Segan D, Sladic D | 55. | AN457 | 2018 | E | FUTURE MEDICINAL CHEMISTRY Vol. 10 (10): # 1177 - 1189 (13), (DOI: 10.4155/fmc-2017-0239) MAY 2018WOS | 22 | 21 | 17 | 0 | 7.0000 | Anticancer properties of the abietane diterpene 6,7-dehydroroyleanone obtained by optimized extraction | Garcia C, Silva C, Monteiro C, Nicolai M, Viana A, Andrade J, Barasoain I, Stankovic T, Quintana J, Hernández I, González I, Estévez F, Díaz-Lanza A, Reis C, Afonso C, Pesic M, Rijo P | 56. | AN457 | 2019 | E | DRUG RESISTANCE UPDATES Vol. 46 (): #100643 - (25), (DOI: 10.1016/j.drup.2019.100643) SEP 2019WOS | 66 | 58 | 5 | 0 | 58.0000 | What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg | Alexa-Stratulat T, Pesic M, Gasparovic A, Trougakos I, Riganti C | 57. | AN457 | 2019 | E | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Vol. 181 (): #111580 - (14), (DOI: 10.1016/j.ejmech.2019.111580) NOV 1 2019WOS | 22 | 21 | 12 | 0 | 10.5000 | Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy | Jovanovic M, Zhukovsky D, Podolski-Renic A, Domraceva I, Zalubovskis R, Sencanski M, Glisic S, Sharoyko V, Tennikova T, Dar'in D, Pesic M, Krasavin M | 58. | AN457 | 2019 | E | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES Vol. 138 (): #105012 - (9), (DOI: 10.1016/j.ejps.2019.105012) OCT 1 2019WOS | 25 | 23 | 8 | 0 | 19.1667 | Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance | Podolski-Renic A, Dinic J, Stankovic T, Jovanovic M, Ramovic A, Pustenko A, Zalubovskis R, Pesic M | 59. | AN457 | 2019 | E | JOURNAL OF ETHNOPHARMACOLOGY Vol. 240 (): #111951 - (10), (DOI: 10.1016/j.jep.2019.111951) AUG 10 2019WOS | 19 | 15 | 7 | 0 | 15.0000 | Potential of Teucrium chamaedrys L. to modulate apoptosis and biotransformation in colorectal carcinoma cells | Milutinovic M, Maksimovic V, Cvetkovic D, Nikodijevic D, Stankovic M, Pesic M, Markovic S | 60. | AN457 | 2019 | E | JOURNAL OF MEDICINAL CHEMISTRY Vol. 62 (3): # 1657 - 1668 (12), (DOI: 10.1021/acs.jmedchem.8b01994) FEB 14 2019WOS | 29 | 26 | 13 | 0 | 11.8182 | Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging | Fási L, Di M, Kuo C, Buric S, Martins A, Kúsz N, Béni Z, Dékány M, Balogh G, Pesic M, Wang H, Trouillas P, Hunyadi A | 61. | AN457 | 2019 | E | ACS OMEGA Vol. 4 (5): # 8094 - 8103 (10), (DOI: 10.1021/acsomega.9b00512) MAY 2019WOS | 34 | 29 | 11 | 0 | 16.1111 | Cytotoxic Activity of Royleanone Diterpenes from Plectranthus madagascariensis Benth | Matias D, Nicolai M, Saraiva L, Pinheiro R, Faustino C, Lanza A, Reis C, Stankovic T, Dinic J, Pesic M, Rijo P | 62. | AN457 | 2019 | E | SCIENTIFIC REPORTS Vol. 9 (): #9332 - (13), (DOI: 10.1038/s41598-019-45863-z) JUN 27 2019WOS | 31 | 27 | 5 | 0 | 27.0000 | Interplay of Darwinian Selection, Lamarckian Induction and Microvesicle Transfer on Drug Resistance in Cancer | Alvarez-Arenas A, Podolski-Renic A, Belmonte-Beitia J, Pesic M, Calvo G | 63. | AN457 | 2019 | E | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY Vol. 34 (1): # 665 - 671 (7), (DOI: 10.1080/14756366.2019.1575372) JAN 1 2019WOS | 6 | 6 | 9 | 0 | 4.2857 | Design, synthesis, and biological evaluation of novel derivatives of dithiodiglycolic acid prepared via oxidative coupling of thiols | Bakulina O, Bannykh A, Jovanovic M, Domraceva I, Podolski-Renic A, Zalubovskis R, Pesic M, Dar'in D, Krasavin M | 64. | AN457 | 2019 | E | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY Vol. 2019 (): #3061607 - (14), (DOI: 10.1155/2019/3061607) 2019WOS | 23 | 18 | 12 | 0 | 9.0000 | Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo | Buric S, Podolski-Renic A, Dinic J, Stankovic T, Jovanovic M, Hadzic S, Ayuso J, Virumbrales-Muñoz M, Fernández L, Ochoa I, Pérez-García V, Pasic M | 65. | AN457 | 2019 | E | CURRENT MEDICINAL CHEMISTRY Vol. 26 (33): # 6074 - 6106 (33), (DOI: 10.2174/0929867325666180607094856) 2019WOS | 47 | 44 | 7 | 0 | 44.0000 | Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment | Stankovic T, Dinic J, Podolski-Renic A, Musso L, Buric S, Dallavalle S, Pesic M | 66. | AN457 | 2019 | E | JOURNAL OF MEDICAL BIOCHEMISTRY Vol. 38 (2): # 188 - 195 (8), (DOI: 10.2478/jomb-2018-0022) APR 2019WOS | 17 | 15 | 7 | 0 | 15.0000 | ASSOCIATION OF OVEREXPRESSED MYC GENE WITH ALTERED PHACTR3 AND E2F4 GENES CONTRIBUTES TO NON-SMALL CELL LUNG CARCINOMA PATHOGENESIS | Dragoj M, Bankovic J, Podolski-Renic A, Buric S, Pesic M, Tanic N, Stankovic T | 67. | AN457 | 2019 | E | BIOMOLECULES Vol. 9 (10): #616 - (13), (DOI: 10.3390/biom9100616) OCT 2019WOS | 13 | 11 | 15 | 0 | 4.2308 | Parvifloron D from Plectranthus strigosus: Cytotoxicity Screening of Plectranthus spp. Extracts | Garcia C, Ntungwe E, Rebelo A, Bessa C, Stankovic T, Dinic J, Díaz-Lanza A, Reis C, Roberto A, Pereira P, Cebola M, Saraiva L, Pesic M, Duarte N, Rijo P | 68. | AN457 | 2019 | E | CANCERS Vol. 11 (6): #848 - (20), (DOI: 10.3390/cancers11060848) JUN 2019WOS | 39 | 36 | 20 | 0 | 10.0000 | A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor | Fallacara A, Zamperini C, Podolski-Renic A, Dinic J, Stankovic T, Stepanovic M, Mancini A, Rango E, Iovenitti G, Molinari A, Bugli F, Sanguinetti M, Torelli R, Martini M, Maccari L, Valoti M, Dreassi E, Botta M, Pesic M, Schenone S | 69. | AN457 | 2019 | E | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Vol. 20 (18): #4575 - (21), (DOI: 10.3390/ijms20184575) SEP 2 2019WOS | 18 | 18 | 8 | 0 | 15.0000 | Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells | Dinic J, Podolski-Renic A, Jovanovic M, Musso L, Tsakovska I, Pajeva I, Dallavalle S, Pesic M | 70. | AN457 | 2020 | M21a+ | E | Review | DRUG RESISTANCE UPDATES Vol. 48 (): #100658 - (19), (DOI: 10.1016/j.drup.2019.100658) JAN 2020WOS | 53 | 51 | 8 | 20.0000 | 51.0000 | Advanced technological tools to study multidrug resistance in cancer | Andrei L, Kasas S, Garrido I, Stankovic T, Korsnes M, Vaclavikova R, Assaraf Y, Pesic M | 71. | AN457 | 2020 | M21a | E | Article | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Vol. 191 (): #112119 - (11), (DOI: 10.1016/j.ejmech.2020.112119) APR 1 2020WOS | 23 | 23 | 9 | 8.5714 | 16.4286 | Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential | Jovanovic M, Zhukovsky D, Podolski-Renic A, Zalubovskis R, Dar'in D, Sharoyko V, Tennikova T, Pesic M, Krasavin M | 72. | AN457 | 2020 | M21a | E | Article | ACS MEDICINAL CHEMISTRY LETTERS Vol. 11 (5): # 839 - 845 (7), (DOI: 10.1021/acsmedchemlett.9b00642) MAY 14 2020WOS | 20 | 18 | 12 | 6.0000 | 9.0000 | Molecular Docking Studies of Royleanone Diterpenoids from Plectranthus spp. as P-Glycoprotein Inhibitors | Isca V, Ferreira R, Garcia C, Monteiro C, Dinic J, Holmstedt S, André V, Pesic M, dos S, Candeias N, Afonso C, Rijo P | 73. | AN457 | 2020 | M21a | E | Article | FRONTIERS IN PHARMACOLOGY Vol. 11 (): #557789 - (10), (DOI: 10.3389/fphar.2020.557789) NOV 17 2020WOS | 17 | 14 | 17 | 4.0000 | 4.6667 | Royleanone Derivatives From Plectranthus spp. as a Novel Class of P-Glycoprotein Inhibitors | Garcia C, Isca V, Pereira F, Monteiro C, Ntungwe E, Sousa F, Dinic J, Holmstedt S, Roberto A, Díaz-Lanza A, Reis C, Pesic M, Candeias N, Ferreira R, Duarte N, Afonso C, Rijo P | 74. | AN457 | 2020 | M21a | E | Article | ANTIOXIDANTS Vol. 9 (6): #519 - (18), (DOI: 10.3390/antiox9060519) JUN 2020WOS | 18 | 13 | 13 | 5.4545 | 5.9091 | Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling | Latif A, Jernei T, Podolski-Renic A, Kuo C, Vágvölgyi M, Girst G, Zupkó I, Develi S, Ulukaya E, Wang H, Pesic M, Csámpai A, Hunyadi A | 75. | AN457 | 2020 | M21a | E | Article | CANCERS Vol. 12 (6): #1570 - (22), (DOI: 10.3390/cancers12061570) JUN 2020WOS | 18 | 15 | 9 | 8.5714 | 10.7143 | Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo | Nesovic M, Rankov A, Podolski-Renic A, Nikolic I, Tasic G, Mancini A, Schenone S, Pesic M, Dinic J | 76. | AN457 | 2020 | M21 | E | Article | INVESTIGATIONAL NEW DRUGS Vol. 38 (3): # 584 - 598 (15), (DOI: 10.1007/s10637-019-00803-6) JUN 2020WOS | 7 | 5 | 7 | 8.0000 | 5.0000 | CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells | Dinic J, Ríos-Luci C, Karpaviciene I, Cikotiene I, Fernandes M, Pesic M, Padrón J | 77. | AN457 | 2020 | M21 | E | Article | FRONTIERS IN MOLECULAR BIOSCIENCES Vol. 7 (): #586146 - (17), (DOI: 10.3389/fmolb.2020.586146) OCT 6 2020WOS | 21 | 19 | 7 | 8.0000 | 19.0000 | Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy | Jovanovic M, Dragoj M, Zhukovsky D, Dar'in D, Krasavin M, Pesic M, Podolski-Renic A | 78. | AN457 | 2020 | M22 | E | Article | JOURNAL OF MOLECULAR RECOGNITION Vol. 33 (12): #e2849 - (14), (DOI: 10.1002/jmr.2849) DEC 2020WOS | 28 | 25 | 17 | 1.6667 | 8.3333 | A perspective view on the nanomotion detection of living organisms and its features | Venturelli L, Kohler A, Stupar P, Villalba M, Kalauzi A, Radotic K, Bertacchi M, Dinarelli S, Girasole M, Pesic M, Bankovic J, Vela M, Yantorno O, Willaert R, Dietler G, Longo G, Kasas S | 79. | AN457 | 2020 | M22 | E | Article | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY Vol. 76 (11): # 1539 - 1546 (8), (DOI: 10.1007/s00228-020-02937-6) NOV 2020WOS | 5 | 2 | 7 | 5.0000 | 2.0000 | Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension | Momcilovic S, Jovanovic A, Radojkovic D, Nikolic V, Jankovic S, Pesic M, Milovanovic J | 80. | AN457 | 2020 | M21 | E | Editorial Material | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY Vol. 2020 (): #2407074 - (3), (DOI: 10.1155/2020/2407074) JUN 3 2020WOS | 4 | 4 | 4 | 0 | 4.0000 | Natural Products: Optimizing Cancer Treatment through Modulation of Redox Balance | Rijo P, Pesic M, Fernandes A, Santos C | 81. | AN457 | 2021 | M21a+ | E | Review | DRUG RESISTANCE UPDATES Vol. 55 (): #100753 - (24), (DOI: 10.1016/j.drup.2021.100753) MAR 2021WOS | 43 | 30 | 8 | 20.0000 | 30.0000 | In vitro biomimetic models for glioblastoma-a promising tool for drug response studies | Stankovic T, Randelovic T, Dragoj M, Buric S, Fernández L, Ochoa I, Pérez-García V, Pesic M | 82. | AN457 | 2021 | M21a | E | Article | CANCERS Vol. 13 (21): #5308 - (17), (DOI: 10.3390/cancers13215308) NOV 2021WOS | 12 | 8 | 9 | 8.5714 | 5.7143 | New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors | Podolski-Renic A, Dinic J, Stankovic T, Tsakovska I, Pajeva I, Tuccinardi T, Botta L, Schenone S, Pesic M | 83. | AN457 | 2021 | M21a | E | Article | PHARMACEUTICS Vol. 13 (6): #825 - (18), (DOI: 10.3390/pharmaceutics13060825) JUN 2021WOS | 10 | 8 | 7 | 12.0000 | 8.0000 | Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment | Neto I, Domínguez-Martín E, Ntungwe E, Reis C, Pesic M, Faustino C, Rijo P | 84. | AN457 | 2021 | M21 | E | Article | MEDICINA-LITHUANIA Vol. 57 (5): #446 - (9), (DOI: 10.3390/medicina57050446) MAY 2021WOS | 8 | 6 | 7 | 8.0000 | 6.0000 | Nano-Motion Analysis for Rapid and Label Free Assessing of Cancer Cell Sensitivity to Chemotherapeutics | Stupar P, Podolski-Renic A, Villalba M, Dragoj M, Stojanov S, Pesic M, Kasas S | 85. | AN457 | 2021 | M21 | E | Review | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS Vol. 1865 (1): #129759 - (11), (DOI: 10.1016/j.bbagen.2020.129759) JAN 2021WOS | 4 | 4 | 7 | 8.0000 | 4.0000 | Protein kinases as targets for developing anticancer agents from marine organisms | Qiao G, Bi K, Liu J, Cao S, Liu M, Pesic M, Lin X | 86. | AN457 | 2021 | M22 | E | Article | BIOLOGIA FUTURA Vol. 72 (2): # 119 - 125 (7), (DOI: 10.1007/s42977-020-00043-3) JUN 2021WOS | 1 | 1 | 6 | 5.0000 | 1.0000 | Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-being | Pesic M, Egamberdieva D, Kolodziejczyk B, Elsässer S, Neergheen V, Kagansky A | 87. | AN457 | 2021 | M22 | E | Article | JOURNAL OF THE SERBIAN CHEMICAL SOCIETY Vol. 86 (12): # 1219 - 1228 (10), (DOI: 10.2298/JSC210806085K) 2021WOS | 4 | 3 | 7 | 5.0000 | 3.0000 | Two new jatrophane diterpenes from the roots of Euphorbia nicaeensis | Krstic G, Kostic A, Jadranin M, Pesic M, Novakovic M, Aljancic I, Vajs V | 88. | AN457 | 2021 | M22 | E | Article | BRAIN SCIENCES Vol. 11 (7): #884 - (14), (DOI: 10.3390/brainsci11070884) JUL 2021WOS | 22 | 16 | 10 | 3.1250 | 10.0000 | Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells | Kostic A, Stojanov S, Podolski-Renic A, Nesovic M, Dragoj M, Nikolic I, Tasic G, Schenone S, Pesic M, Dinic J | 89. | AN457 | 2021 | M22 | E | Article | BRAIN SCIENCES Vol. 11 (8): #1025 - (12), (DOI: 10.3390/brainsci11081025) AUG 2021WOS | 16 | 11 | 7 | 5.0000 | 11.0000 | Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing | Dragoj M, Stojkovska J, Stankovic T, Dinic J, Podolski-Renic A, Obradovic B, Pesic M | 90. | AN457 | 2021 | M22 | E | Correction | BIOLOGIA FUTURA Vol. 72 (2): # 127 - 127 (1), (DOI: 10.1007/s42977-020-00045-1) JUN 2021WOS | 0 | 0 | 6 | 0 | 0.0000 | Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-being (Aug, 10.1007/s42977-020-00043-3, 2020) | Pesic M, Egamberdieva D, Kolodziejczyk B, Elsässer S, Neergheen V, Kagansky A | 91. | AN457 | 2022 | M21a+ | E | Article | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Vol. 228 (): #113980 - (16), (DOI: 10.1016/j.ejmech.2021.113980) JAN 15 2022WOS | 5 | 4 | 7 | 20.0000 | 4.0000 | Straightforward access to novel mitochondriotropics derived from 2-arylethanol as potent and selective antiproliferative agents | Hicke F, Puerta A, Dinic J, Pesic M, Padrón J, López O, Fernández-Bolaños J | 92. | AN457 | 2022 | M21a | E | Article | ACS MEDICINAL CHEMISTRY LETTERS Vol. 13 (4): # 674 - 680 (7), (DOI: 10.1021/acsmedchemlett.1c00711) APR 14 2022WOS | 11 | 10 | 9 | 8.5714 | 7.1429 | C20-nor-Abietane and Three Abietane Diterpenoids fromPlectranthus mutabilisLeaves as P-Glycoprotein Modulators | Ntungwe E, Stojanov S, Duarte N, Candeias N, Díaz-Lanza A, Vágvölgyi M, Hunyadi A, Pesic M, Rijo P | 93. | AN457 | 2022 | M21 | E | Article | NEURO-ONCOLOGY ADVANCES Vol. 4 (1): #vdac155 - (13), (DOI: 10.1093/noajnl/vdac155) JAN 1 2022WOS | 9 | 4 | 10 | 5.0000 | 2.5000 | On optimal temozolomide scheduling for slowly growing glioblastomas | Segura-Collar B, Jiménez-Sánchez J, Gargini R, Dragoj M, Sepúlveda-Sánchez J, Pesi M, Ramírez M, Ayala-Hernández L, Sánchez-Gómez P, Pérez-García V | 94. | AN457 | 2022 | M21 | E | Article | LIFE-BASEL Vol. 12 (9): #1291 - (14), (DOI: 10.3390/life12091291) SEP 2022WOS | 7 | 5 | 8 | 6.6667 | 4.1667 | Decreased TSPAN14 Expression Contributes to NSCLC Progression | Jovanovic M, Stankovic T, Buric S, Bankovic J, Dinic J, Ljujic M, Pesic M, Dragoj M | 95. | AN457 | 2022 | M21 | E | Article | LIFE-BASEL Vol. 12 (10): #1503 - (18), (DOI: 10.3390/life12101503) OCT 2022WOS | 8 | 4 | 7 | 8.0000 | 4.0000 | Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors | Stojanov S, Kostic A, Ljujic M, Lupsic E, Schenone S, Pesic M, Dinic J | 96. | AN457 | 2022 | M21 | E | Review | FRONTIERS IN MOLECULAR BIOSCIENCES Vol. 9 (): #883297 - (16), (DOI: 10.3389/fmolb.2022.883297) MAY 19 2022WOS | 44 | 29 | 4 | 8.0000 | 29.0000 | The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance | Jovanovic M, Podolski-Renic A, Krasavin M, Pesic M | 97. | AN457 | 2023 | M21a+ | E | Review | TRENDS IN MOLECULAR MEDICINE Vol. 29 (3): # 173 - 187 (15), (DOI: 10.1016/j.molmed.2022.12.002) MAR 2023WOS | 24 | 13 | 19 | 7.1429 | 4.6429 | Biodiversity: the overlooked source of human health | Linhares Y, Kaganski A, Agyare C, Kurnaz I, Neergheen V, Kolodziejczyk B, Kedra M, Wahajuddin M, El-Youssf L, dela C, Baran Y, Pesic M, Shrestha U, Bakiu R, Allard P, Rybtsov S, Pieri M, Siciliano V, Bueso Y | 98. | AN457 | 2023 | M21a | E | Article | BIOORGANIC CHEMISTRY Vol. 133 (): #106410 - (14), (DOI: 10.1016/j.bioorg.2023.106410) APR 2023WOS | 13 | 5 | 14 | 5.0000 | 2.0833 | Biotinylated selenocyanates: Potent and selective cytostatic agents | Roldán-Peña J, Puerta A, Dinic J, Stojanov S, González-Bakker A, Hicke F, Mishra A, Piyasaengthong A, Maya I, Walton J, Pesic M, Padrón J, Fernández-Bolaños J, López O | 99. | AN457 | 2023 | M21a | E | Article | BIOORGANIC CHEMISTRY Vol. 138 (): #106605 - (22), (DOI: 10.1016/j.bioorg.2023.106605) SEP 2023WOS | 9 | 3 | 9 | 8.5714 | 2.1429 | Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells | Stojkovic P, Kostic A, Lupsic E, Jovanovic N, Novakovic M, Nedialkov P, Trendafilova A, Pesic M, Opsenica I | 100. | AN457 | 2023 | M21a | E | Article | PHARMACEUTICS Vol. 15 (7): #1942 - (14), (DOI: 10.3390/pharmaceutics15071942) JUL 2023WOS | 3 | 1 | 7 | 12.0000 | 1.0000 | Coleon U, Isolated from Plectranthus mutabilis Codd., Decreases P-Glycoprotein Activity Due to Mitochondrial Inhibition | Stojanov S, Ntungwe E, Dinic J, Podolski-Renic A, Pajovic M, Rijo P, Pesic M | 101. | AN457 | 2023 | M21 | E | Article | BULLETIN OF MATHEMATICAL BIOLOGY Vol. 85 (1): #8 - (27), (DOI: 10.1007/s11538-022-01113-4) JAN 2023WOS | 8 | 6 | 6 | 8.0000 | 6.0000 | Stochastic Fluctuations Drive Non-genetic Evolution of Proliferation in Clonal Cancer Cell Populations | Ortega-Sabater C, Calvo G, Dinic J, Podolski A, Pesic M, Pérez-García V | 102. | AN457 | 2023 | M21 | E | Article | DIAGNOSTICS Vol. 13 (24): #3617 - (18), (DOI: 10.3390/diagnostics13243617) DEC 2023WOS | 10 | 3 | 12 | 4.0000 | 1.5000 | Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells | Dinic J, Podolski-Renic A, Dragoj M, Stojanov S, Stepanovic A, Lupsic E, Pajovic M, Jovanovic M, Rodic D, Maric D, Ercegovac M, Pesic M | 103. | AN457 | 2023 | M21 | E | Article | PLANTS-BASEL Vol. 12 (24): #4181 - (22), (DOI: 10.3390/plants12244181) DEC 2023WOS | 2 | 0 | 8 | 6.6667 | 0.0000 | LC-ESI QToF MS Non-Targeted Screening of Latex Extracts of Euphorbia seguieriana ssp. seguieriana Necker and Euphorbia cyparissias and Determination of Their Potential Anticancer Activity | Jadranin M, Savic D, Lupsic E, Podolski-Renic A, Pesic M, Tesevic V, Milosavljevic S, Krstic G | 104. | AN457 | 2023 | M22 | E | Article | NEW JOURNAL OF CHEMISTRY Vol. 47 (14): # 6844 - 6855 (12), (DOI: 10.1039/d3nj00427a) APR 3 2023WOS | 6 | 2 | 10 | 3.1250 | 1.2500 | Novel artesunate-pyrimidine-based hybrids with anticancer potential against multidrug-resistant cancer cells | Koracak L, Lupsic E, Jovanovic N, Jovanovic M, Novakovic M, Nedialkov P, Trendafilova A, Zlatovic M, Pesic M, Opsenica I | 105. | AN457 | 2024 | M21a+ | E | Article | BIOMEDICINE & PHARMACOTHERAPY Vol. 174 (): #116496 - (19), (DOI: 10.1016/j.biopha.2024.116496) MAY 2024WOS | 8 | 2 | 7 | 20.0000 | 2.0000 | Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma | Stepanovic A, Jovanovic N, Korac A, Zlatovic M, Nikolic I, Opsenica I, Pesic M | 106. | AN457 | 2024 | M21a+ | E | Review | BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER Vol. 1879 (6): #189220 - (12), (DOI: 10.1016/j.bbcan.2024.189220) NOV 2024WOS | 5 | 1 | 8 | 20.0000 | 1.0000 | New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas | Yao H, Luo L, Li R, Zhao Y, Zhang L, Pesic M, Cai L, Li L | 107. | AN457 | 2024 | M21a | E | Article | BIOORGANIC CHEMISTRY Vol. 145 (): #107168 - (16), (DOI: 10.1016/j.bioorg.2024.107168) APR 2024WOS | 9 | 2 | 17 | 4.0000 | 0.6667 | Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases | Fuentes-Aguilar A, González-Bakker A, Jovanovic M, Stojanov S, Puerta A, Gargano A, Dinic J, Vega-Báez J, Merino-Montiel P, Montiel-Smith S, Alcaro S, Nocentini A, Pesic M, Supuran C, Padrón J, Fernández-Bolaños J, López O | 108. | AN457 | 2024 | M21 | E | Article | CANCERS Vol. 16 (11): #1984 - (25), (DOI: 10.3390/cancers16111984) JUN 2024WOS | 4 | 2 | 12 | 4.0000 | 1.0000 | Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors | Dinic J, Dragoj M, Stojanov S, Stepanovic A, Lupsic E, Pajovic M, Mohr T, Glumac S, Maric D, Ercegovac M, Podolski-Renic A, Pesic M | 109. | AN457 | 2024 | M21 | E | Review | LIFE-BASEL Vol. 14 (9): #1142 - (33), (DOI: 10.3390/life14091142) SEP 2024WOS | 2 | 0 | 6 | 8.0000 | 0.0000 | Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine | Dinic J, Stojanov S, Dragoj M, Grozdanic M, Podolski-Renic A, Pesic M | 110. | AN457 | 2024 | M21 | E | Review | MOLECULES Vol. 29 (18): #4308 - (32), (DOI: 10.3390/molecules29184308) SEP 2024WOS | 0 | 0 | 6 | 8.0000 | 0.0000 | Plant-Based Products Originating from Serbia That Affect P-glycoprotein Activity | Dinic J, Podolski-Renic A, Novakovic M, Li L, Opsenica I, Pesic M | 111. | AN457 | 2024 | M21a | E | Editorial Material | FRONTIERS IN PHARMACOLOGY Vol. 15 (): #1484339 - (3), (DOI: 10.3389/fphar.2024.1484339) SEP 3 2024WOS | 0 | 0 | 4 | 0 | 0.0000 | Editorial: Natural products and nanoparticles in cancer treatment: is there a light at the end of the tunnel? | Pesic M, Chahardehi A, Echeverria J, Talib W | 112. | AN457 | 2025 | E | BIOORGANIC CHEMISTRY Vol. 165 (): #108967 - (21), (DOI: 10.1016/j.bioorg.2025.108967) OCT 2025WOS | 1 | 0 | 8 | 0 | 0.0000 | Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells | Stojkovic P, Lupsic E, Jovanovic N, Stepanovic A, Nedialkov P, Podolski-Renic A, Pesic M, Opsenica I | 113. | AN457 | 2025 | E | JOURNAL OF DRUG TARGETING Vol. 33 (3): # 368 - 383 (16), (DOI: 10.1080/1061186X.2024.2427185) MAR 16 2025WOS | 1 | 0 | 9 | 0 | 0.0000 | Drug screening approaches for small-molecule compounds in cancer-targeted therapy | Zhao Y, Yuan C, Shi Y, Liu X, Luo L, Zhang L, Pesic M, Yao H, Li L | 114. | AN457 | 2025 | E | ONCOLOGIE Vol. 27 (5): # 697 - 710 (14), (DOI: 10.1515/oncologie-2025-0228) SEP 24 2025WOS | 0 | 0 | 8 | 0 | 0.0000 | Impact of ex vivo cell culturing on ABC transporters' expression and drug sensitivity in patient-derived non-small cell lung cancer models | Dinic J, Stojanov S, Lupsic E, Pajovic M, Stepanovic A, Dragoj M, Podolski-Renic A, Pesic M | 115. | AN457 | 2025 | E | FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY Vol. 13 (): #1677261 - (15), (DOI: 10.3389/fcell.2025.1677261) OCT 24 2025WOS | 0 | 0 | 16 | 0 | 0.0000 | PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation | Grdovic N, Tolic A, Jovanovic M, Rajic J, Dordevic M, Stojanovic M, Hadzic S, Markovic T, Saric A, Dinic S, Jovanovic J, Mihailovic M, Podolski-Renic A, Pesic M, Vidakovic M, Uskokovic A | 116. | AN457 | 2025 | E | CURRENT ISSUES IN MOLECULAR BIOLOGY Vol. 47 (4): #281 - (17), (DOI: 10.3390/cimb47040281) APR 17 2025WOS | 0 | 0 | 11 | 0 | 0.0000 | Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures | Podolski-Renic A, Stojanov S, Maric D, Dinic J, Dragoj M, Stepanovic A, Lupsic E, Pajovic M, Glumac S, Ercegovac M, Pesic M | 117. | AN457 | 2025 | E | MOLECULES Vol. 30 (24): #4756 - (22), (DOI: 10.3390/molecules30244756) DEC 12 2025WOS | 0 | 0 | 10 | 0 | 0.0000 | Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells | Lupsic E, Stojkovic P, Grozdanic M, Terzic-Jovanovic N, Pajovic M, Koutsougianni F, Alexopoulou D, Opsenica I, Pesic M, Podolski-Renic A | 118. | AN457 | 2025 | E | PHARMACEUTICS Vol. 17 (2): #189 - (23), (DOI: 10.3390/pharmaceutics17020189) FEB 2025WOS | 1 | 0 | 9 | 0 | 0.0000 | LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models | Podolski-Renic A, Chigriai M, Stojanov S, Grozdanic M, Lupsic E, Nikolic I, Dragoj M, Dinic J, Pesic M | 119. | AN457 | 2025 | E | PHARMACEUTICS Vol. 17 (7): #815 - (4), (DOI: 10.3390/pharmaceutics17070815) JUN 24 2025WOS | 0 | 0 | 3 | 0 | 0.0000 | Novel Therapeutic Strategies for Glioblastoma | Podolski-Renic A, Dinic J, Pesic M | 120. | AN457 | 2026 | E | BIOORGANIC CHEMISTRY Vol. 168 (): #109307 - (24), (DOI: 10.1016/j.bioorg.2025.109307) JAN 2026WOS | 0 | 0 | 10 | 0 | 0.0000 | Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity | Koracak L, Ajdacic V, Selakovic M, Pajovid M, Novakovic M, Lupsic E, Podolski-Renic A, Zlatovic M, Pesic M, Opsenica I | 121. | AN457 | 2026 | E | FUTURE MEDICINAL CHEMISTRY Vol. 18 (1): # 67 - 78 (12), (DOI: 10.1080/17568919.2025.2602963) JAN 2 2026WOS | 0 | 0 | 6 | 0 | 0.0000 | Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate-pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with P-glycoprotein | Mosic M, Koracak L, Grozdanic M, Jovanovic N, Pesic M, Segan S |
|---|
27. 04. 2026.; 00:10:03; Trajanje procesiranja: 0.047 s
Legenda:
RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora
Primer:
Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.
Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.
Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).